Back to Articles
GeneralBusiness Today

Here’s why ChrysCapital expects 20-25% of the latest $2.2-billion fund to go to pharma, healthcare

PE firm expands into selective control deals as it looks for opportunities in domestic formulations and API/CDMO

Attribution

This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.

Read on Business Today

More Articles